1[1]Zacharieva S,Orbetzova D,Tcharaktchiev D,et al.Effects of shortterm treatment with the thromboxane synthesis blocker indobufen on pressor and depressor humoral factors in healthy humans[J].Methods Find Exp Clin Pharmacol,1995,17 (9):615 -619.
2[2]Mannucci L,Maderna P,Colli S,et al.Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk[J].Thromb Res,1987,48(4):417 -426.
3[3]Glowka F K.Stereoselecrive pharmacokinetics of vention in nonrheu-matic atria fibrillation after ansietischaemic attack or minor stroke[J].Lancet,1993,342 (8):1255.
4[4]Battaglia A,Stragliotto E,Heiman F,et al.Indobufen in the secondary prevention of cerebral ischemic attack (TIA):a prospective,randomized,controlled study[abstract number 2896][J].Thromb Haemost,199 3,69 (6):1349.
5[5]EAFT(Euro pean Atria Fibrillation Trial) Stidu up.Secondary prevention in non-rheumatic atria fibrillation after transient ischaemic attack of minor stroke[J].Lancet,1993,342 (1):8-14.
6[6]Fornaro G,Rossi P,Mantica P G,et al.Indobufen in the prevention of thromboembolic complications in patients with heart disease:a randomized,placebo-controlled,double-blind study[J].Circulation,1993,87(1):162.
8[8]Rajah S M,Nair U,Rees M,et al.Effects of antip-atelet therapy with indobufen or aspirin-dipyridaole on graft patency one year after coronary artery bypass grafting[J].J Thorac Cardiovasc Surg,1994,107(4):1146.
9[9]Bennett C L,Connors J M,Carwil J M,et al.Thrmboic thrombocytopenic purpura associated with clopidogrel[J].N Engl J Med,2000,342(24):1773-1777.
10[10]Moher D,Pham B,Ausejo M,et al.Pharmacological management of intermittent claudication:a metaanalysisi of randomized trials[J].Drugs,2000,59(5):1057.
